Publication | Closed Access

The impact of repeated cycles of radioligand therapy using [177Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer

UrologySurgical OncologyRadioligand TherapyRenal FunctionGenitourinary CancerMedicineRadiopharmaceutical TherapyRepeated CyclesProstatic DiseaseOncologyNephrologyEndocrine-related CancerRadiology